Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
ChargePoint Technology has announced the appointment of Kieran Coulton as Chairman.
read more
Cobra Biologics has signed an agreement with AstraZeneca to manufacture the adenovirus vector-based COVID-19 vaccine candidate AZD1222.
read more
Batavia Biosciences and Valneva Sweden have entered into a collaboration agreement to accelerate market-access of a low-cost IPV.
read more
Longhorn Vaccines & Diagnostics and Pharmco have combined to rapidly accelerate coronavirus testing and detection which are critical to combating the global COVID-19 pandemic.
read more
Catalent announced Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca PLC at Catalent’s manufacturing facility in Anagni, Italy.
read more
Luminer has streamlined its product inspection capabilities by introducing a dedicated 7,000-square-foot inspection suite at its primary manufacturing facility in Lakewood, NJ.
read more
Cascade Chemistry has been selected to produce the active pharmaceutical ingredient (API) for clinical trial supplies of RBT-9.
read more
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
Mapi Pharma announced an additional investment from Mylan in support of continued study progress to bring to market in the U.S. Glatiramer Acetate Depot.
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more
Jacobs has been selected to provide EPCMCQV to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
read more
Lupin is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP 500mg, lot G901203 to the consumer level.
read more
Almac Group has reported an £85.4 million rise in turnover from £548.9 million to £634.3 million for its financial year 2018-19.
read more